February 25, 2019
Diplomat Pharmacy misled investors about the success of a new business venture, causing a 56 percent plunge in stock price when the company revealed it would have to write off millions in goodwill and assets, a shareholder told a California federal court in a proposed class action complaint filed Sunday.